Audited Financial Statements (Standalone and Consolidated) for quarter & year ended March 31, 2026 along with auditors report thereon, along with information for AGM and Dividend
FERMENTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fermenta Biotech reported standalone total income of Rs. 4,422.09 lakh for FY2026, marginally lower than Rs. 4,502.53 lakh in FY2025, while consolidated total income rose to Rs. 5,478.15 lakh from Rs. 5,254.29 lakh. Standalone profit after tax increased 5.2% to Rs. 676.15 lakh, and consolidated PAT grew 8.7% to Rs. 764.03 lakh. Basic EPS stood at Rs. 23.18 on standalone basis. The board recommended a final dividend of Rs. 3.75 per share (75% on Rs. 5 face value). Statutory auditors SRBC & Co. LLP issued unmodified opinions on both standalone and consolidated financial statements. Exceptional items included Rs. 210.52 lakh for provident fund obligations and Rs. 907.14 lakh recovery of previously written-off receivables. The 74th AGM is scheduled for August 11, 2026.
The company delivered modest PAT growth on both standalone and consolidated bases despite flat-to-negative revenue, indicating improved operational efficiency. The 75% dividend payout signals confidence in financial stability and rewards shareholders. Clean audit opinions support financial transparency.